1,873 Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC) Bought by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,873 shares of the company’s stock, valued at approximately $170,000.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Vanguard Group Inc. grew its stake in shares of GE HealthCare Technologies by 14.7% in the 3rd quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after buying an additional 5,693,244 shares in the last quarter. Norges Bank bought a new position in GE HealthCare Technologies in the fourth quarter valued at approximately $229,052,000. Capital Research Global Investors boosted its stake in shares of GE HealthCare Technologies by 2.8% in the fourth quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock valued at $3,969,975,000 after buying an additional 1,401,566 shares during the period. Perpetual Ltd acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $96,135,000. Finally, Stonegate Investment Group LLC raised its holdings in shares of GE HealthCare Technologies by 3,555.0% during the fourth quarter. Stonegate Investment Group LLC now owns 654,391 shares of the company’s stock valued at $50,598,000 after purchasing an additional 636,487 shares during the period. Institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In related news, insider Frank R. Jimenez purchased 1,315 shares of the stock in a transaction that occurred on Wednesday, May 1st. The shares were bought at an average price of $76.52 per share, with a total value of $100,623.80. Following the acquisition, the insider now owns 75,796 shares of the company’s stock, valued at approximately $5,799,909.92. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, insider Frank R. Jimenez acquired 1,315 shares of the firm’s stock in a transaction dated Wednesday, May 1st. The stock was purchased at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CTO Taha Kass-Hout sold 3,300 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now directly owns 67,300 shares in the company, valued at approximately $5,296,510. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 90,482 shares of company stock worth $7,369,137. Company insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on GEHC shares. Citigroup lifted their price objective on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. The Goldman Sachs Group initiated coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price objective on the stock. Argus raised their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Finally, Bank of America cut their price objective on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Five analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $94.09.

Get Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $76.35 on Tuesday. The firm has a market capitalization of $34.85 billion, a PE ratio of 22.32, a P/E/G ratio of 2.77 and a beta of 1.20. The company’s 50 day simple moving average is $78.69 and its 200 day simple moving average is $81.90. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a debt-to-equity ratio of 1.11, a current ratio of 1.06 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last posted its earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. The company had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period in the previous year, the company earned $0.85 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be issued a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.16%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Stories

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.